Personalised brain cancer treatment shows potential
EU-funded researchers have demonstrated huge potential for treating aggressive brain cancer using actively personalised immunotherapy in a first first-stage clinical trial to test the vaccine's safety.
Source: EUROPA - Research Information Centre - Category: Research Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Immunotherapy | Neurology | Research | Vaccines